Preclinical models of Parkinson's disease.

Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.]

Volumn Chapter 9, Issue , 2001, Pages

  Bankiewicz, K S ^a   Sanchez Pernaute, R ^a   Oiwa, Y ^a   Kohutnicka, M ^a   Cummins, A ^a   Eberling, J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; LEVODOPA; NEUROTOXIN; OXIDOPAMINE;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HOSPITALIZATION; INTOXICATION; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MACACA; MARMOSET; METHODOLOGY; MOTOR ACTIVITY; MOUSE; PARKINSONISM; PATHOPHYSIOLOGY; PRIMATE; RAT; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CALLITHRIX; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; LEVODOPA; MACACA FASCICULARIS; MACACA MULATTA; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING; NEUROTOXINS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PRIMATES; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; SPECIES SPECIFICITY;

MLCS; MLOWN;

EID: 43249098671     PISSN: None     EISSN: 19348576     Source Type: Journal    
DOI: 10.1002/0471140856.tx0108s18     Document Type: Article

References (0)